Melbourne, Australia, November 09, 2017 – Telix Pharmaceuticals Limited has successfully raised $50 million following the close of its fully underwritten Initial Public Offering (IPO). The IPO was strongly supported by institutional investors internationally and domestically, as well as by retail investors in Australia. The full press release can be found here.